CPI-17 Rabbit Polyclonal Antibody

CPI-17 Rabbit Polyclonal Antibody

To Order Now: info@attr-meeting.com

CPI-17 Polyclonal Antibody
ABP57045-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38
  • Applications tips:
Description: A polyclonal antibody for detection of CPI-17 from Human, Mouse, Rat. This CPI-17 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38
CPI-17 Polyclonal Antibody
ABP57045-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38
  • Applications tips:
Description: A polyclonal antibody for detection of CPI-17 from Human, Mouse, Rat. This CPI-17 antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the non-phosphorylation site of T38
CPI-17 Polyclonal Antibody
ES8044-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against CPI-17 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA
CPI-17 Polyclonal Antibody
ES8044-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against CPI-17 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, IF, WB, ELISA
CPI-17 (phospho Thr38) Polyclonal Antibody
ABP57044-003ml 0.03ml
EUR 158
  • Immunogen information: Synthesized peptide derived from human CPI-17 around the phosphorylation site of T38
  • Applications tips:
Description: A polyclonal antibody for detection of CPI-17 phospho Thr38) from Human, Mouse, Rat. This CPI-17 phospho Thr38) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the phosphorylation site of T38
CPI-17 (phospho Thr38) Polyclonal Antibody
ABP57044-01ml 0.1ml
EUR 289
  • Immunogen information: Synthesized peptide derived from human CPI-17 around the phosphorylation site of T38
  • Applications tips:
Description: A polyclonal antibody for detection of CPI-17 phospho Thr38) from Human, Mouse, Rat. This CPI-17 phospho Thr38) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the phosphorylation site of T38
CPI-17 (phospho Thr38) Polyclonal Antibody
ABP57044-02ml 0.2ml
EUR 414
  • Immunogen information: Synthesized peptide derived from human CPI-17 around the phosphorylation site of T38
  • Applications tips:
Description: A polyclonal antibody for detection of CPI-17 phospho Thr38) from Human, Mouse, Rat. This CPI-17 phospho Thr38) antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human CPI-17 around the phosphorylation site of T38
CPI-17 (phospho Thr38) Polyclonal Antibody
ES8043-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against CPI-17 (phospho Thr38) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA
CPI-17 (phospho Thr38) Polyclonal Antibody
ES8043-50ul 50ul
EUR 207
Description: A Rabbit Polyclonal antibody against CPI-17 (phospho Thr38) from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA
Human CPI-17 Antibody
32203-05111 150 ug
EUR 261
Anti-CPI-17 antibody
STJ92448 200 µl
EUR 197
Description: Rabbit polyclonal to CPI-17.
Human CPI-17 Antibody (Biotin Conjugate)
32203-05121 150 ug
EUR 369
Anti-Phospho-CPI-17 (T38) antibody
STJ90233 200 µl
EUR 197
Description: Rabbit polyclonal to Phospho-CPI-17 (T38).
Human CPI-17 AssayLite Antibody (FITC Conjugate)
32203-05141 150 ug
EUR 428
Human CPI-17 AssayLite Antibody (RPE Conjugate)
32203-05151 150 ug
EUR 428
Human CPI-17 AssayLite Antibody (APC Conjugate)
32203-05161 150 ug
EUR 428
Human CPI-17 AssayLite Antibody (PerCP Conjugate)
32203-05171 150 ug
EUR 471
Monoclonal CPI-17 alpha Antibody (N-term), Clone: E305
APR15570G 0.1ml
EUR 528
Description: A Monoclonal antibody against Human CPI-17 alpha (N-term). The antibodies are raised in Rabbit and are from clone E305. This antibody is applicable in WB and IHC
CPI-455
B1881-25
EUR 588
CPI-455
B1881-5
EUR 185
CPI-444
B1970-25
EUR 631
CPI-444
B1970-5
EUR 196
CPI-1205
B2509-1
EUR 142
CPI-1205
B2509-5
EUR 370
CPI-169
B4678-10 10 mg
EUR 270
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).
CPI-169
B4678-100 100 mg
EUR 1442
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).
CPI-169
B4678-5 5 mg
EUR 206
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).
CPI-169
B4678-5.1 10 mM (in 1mL DMSO)
EUR 522
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).
CPI-169
B4678-50 50 mg
EUR 856
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).
CPI-360
B4836-1 1 mg
EUR 126
CPI-360
B4836-10 10 mg
EUR 534
CPI-360
B4836-5 5 mg
EUR 312
CPI-203
B1081-1 1 mg
EUR 128
Description: CPI-203 is a potent, selectivie and competitive small molecule inhibitor of BET bromodomain with a mean GI50 value of 0.23?M in MCL cell lines [1].As an inhibitor of BET proteins, CPI-203 inhibits BRD4 in vitro and in cells.
CPI-203
B1081-5 5 mg
EUR 366
Description: CPI-203 is a potent, selectivie and competitive small molecule inhibitor of BET bromodomain with a mean GI50 value of 0.23?M in MCL cell lines [1].As an inhibitor of BET proteins, CPI-203 inhibits BRD4 in vitro and in cells.
CPI-0610
B1201-25
EUR 588
CPI-0610
B1201-5
EUR 185
CPI-1189
B6109-25 25 mg
EUR 496
Description: CPI-1189 is a proapoptotic cytokine tumor necrosis factor (TNF) alpha inhibitor.AIDS dementia complex is characterized by increased gliosis, apoptosis, and oxidative stress in the CNS, as well as a compromised blood-brain barrier.
CPI-1189
B6109-5 5 mg
EUR 171
Description: CPI-1189 is a proapoptotic cytokine tumor necrosis factor (TNF) alpha inhibitor.AIDS dementia complex is characterized by increased gliosis, apoptosis, and oxidative stress in the CNS, as well as a compromised blood-brain barrier.
CPI-203
9404-1
EUR 131
CPI-203
9404-5
EUR 370
CPI-613
9464-10
EUR 142
CPI-613
9464-50
EUR 414
CPI-637
B7801-10 10 mg
EUR 168
Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor.
CPI-637
B7801-50 50 mg
EUR 453
Description: IC50: 0.03 and 11.0 ?M for CBP/EP300 and BRD4, respectively.CPI-637 is a CBP/EP300 bromodomain inhibitor.
CPI-455
B7811-25 25 mg
EUR 453
Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs).
CPI-455
B7811-5 5 mg
EUR 168
Description: IC50: 10 nMCPI-455 is a KDM5 inhibitor.The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs).
CPI-1205
B7819-10 10 mg
EUR 440
Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3.
CPI-1205
B7819-25 25 mg
EUR 902
Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3.
CPI-1205
B7819-5 5 mg
EUR 270
Description: 0.002 ?M for biochemical IC50; 0.032 ?M for cellular EC50. CPI-1205 is an EZH2 inhibitor.Polycomb repressive complex 2 (PRC2) plays a key role in transcriptional silencing partially by installing methylation marks on lysine 27 of histone 3.
CPI-613
A4333-10 10 mg
EUR 125
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.
CPI-613
A4333-100 100 mg
EUR 258
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.
CPI-613
A4333-5 5 mg
EUR 108
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.
CPI-613
A4333-5.1 10 mM (in 1mL DMSO)
EUR 119
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.
CPI-613
A4333-50 50 mg
EUR 212
Description: CPI-613 is a first-in-class anti-cancer agent [1].CPI-613 is developed to target the pyruvate dehydrogenase complex which is a key mitochondrial enzyme of anaerobic glycolysis in tumor cells.
CPI-455
HY-100421 5mg
EUR 173
CPI-637
HY-100482 100mg
EUR 1042
CPI-0610
HY-12863 10mM/1mL
EUR 163
CPI-203
HY-15846 2mg
EUR 133
CPI-360
HY-15955 100mg
EUR 2391

CPI-17 Rabbit Polyclonal Antibody